{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:46:21Z","timestamp":1789173981719,"version":"build-2803163510"},"reference-count":260,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Genet"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1038\/s41576-026-00947-1","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:01:45Z","timestamp":1774270905000},"page":"603-621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Genetic influences on haematopoiesis"],"prefix":"10.1038","volume":"27","author":[{"given":"Michael","family":"Poeschla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0044-443X","authenticated-orcid":false,"given":"Vijay G.","family":"Sankaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"947_CR1","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2021.10.006","volume":"42","author":"J Cosgrove","year":"2021","unstructured":"Cosgrove, J., Hustin, L. S. P., de Boer, R. J. & Peri\u00e9, L. Hematopoiesis in numbers. Trends Immunol. 42, 1100\u20131112 (2021).","journal-title":"Trends Immunol."},{"key":"947_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nature04957","volume":"441","author":"DT Scadden","year":"2006","unstructured":"Scadden, D. T. The stem-cell niche as an entity of action. Nature 441, 1075\u20131079 (2006).","journal-title":"Nature"},{"key":"947_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-cellbio-020520-114601","volume":"36","author":"JN Pucella","year":"2020","unstructured":"Pucella, J. N., Upadhaya, S. & Reizis, B. The source and dynamics of adult hematopoiesis: insights from lineage tracing. Annu. Rev. Cell Dev. Biol. 36, 529\u2013550 (2020).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"947_CR4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.immuni.2025.07.001","volume":"58","author":"N Lam","year":"2025","unstructured":"Lam, N. et al. Asynchronous aging and turnover of human circulating and tissue-resident memory T cells across sites. Immunity 58, 2271\u20132288.e6 (2025).","journal-title":"Immunity"},{"key":"947_CR5","unstructured":"Bunn, H. F. & Aster, J. C. Pathophysiology of Blood Disorders 2nd edn (McGraw Hill, 2017)."},{"key":"947_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41577-024-00998-7","volume":"24","author":"JW Swann","year":"2024","unstructured":"Swann, J. W., Olson, O. C. & Passegu\u00e9, E. Made to order: emergency myelopoiesis and demand-adapted innate immune cell production. Nat. Rev. Immunol. 24, 596\u2013613 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"947_CR7","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1182\/blood-2011-12-380113","volume":"119","author":"H Takizawa","year":"2012","unstructured":"Takizawa, H., Boettcher, S. & Manz, M. G. Demand-adapted regulation of early hematopoiesis in infection and inflammation. Blood 119, 2991\u20133002 (2012).","journal-title":"Blood"},{"key":"947_CR8","doi-asserted-by":"publisher","first-page":"a011692","DOI":"10.1101\/cshperspect.a011692","volume":"2","author":"TN Williams","year":"2012","unstructured":"Williams, T. N. & Weatherall, D. J. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb. Perspect. Med. 2, a011692 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"947_CR9","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/180326a0","volume":"180","author":"VM Ingram","year":"1957","unstructured":"Ingram, V. M. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180, 326\u2013328 (1957). This paper demonstrated that a single amino acid change causes human disease, establishing the molecular basis of sickle cell disease.","journal-title":"Nature"},{"key":"947_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/251392a0","volume":"251","author":"JM Taylor","year":"1974","unstructured":"Taylor, J. M. et al. Genetic lesion in homozygous \u03b1 thalassaemia (hydrops fetalis). Nature 251, 392\u2013393 (1974).","journal-title":"Nature"},{"key":"947_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/255255a0","volume":"255","author":"YW Kan","year":"1975","unstructured":"Kan, Y. W. et al. Deletion of \u03b1-globin genes in haemoglobin-H disease demonstrates multiple \u03b1-globin structural loci. Nature 255, 255\u2013256 (1975).","journal-title":"Nature"},{"key":"947_CR12","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1073\/pnas.76.6.2886","volume":"76","author":"JC Chang","year":"1979","unstructured":"Chang, J. C. & Kan, Y. W. Beta 0 thalassemia, a nonsense mutation in man. Proc. Natl Acad. Sci. USA 76, 2886\u20132889 (1979).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"947_CR13","doi-asserted-by":"publisher","first-page":"5041","DOI":"10.1073\/pnas.78.8.5041","volume":"78","author":"SH Orkin","year":"1981","unstructured":"Orkin, S. H., Goff, S. C. & Hechtman, R. L. Mutation in an intervening sequence splice junction in man. Proc. Natl Acad. Sci. USA 78, 5041\u20135045 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"947_CR14","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1073\/pnas.78.4.2455","volume":"78","author":"RA Spritz","year":"1981","unstructured":"Spritz, R. A. et al. Base substitution in an intervening sequence of a beta+-thalassemic human globin gene. Proc. Natl Acad. Sci. USA 78, 2455\u20132459 (1981).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"947_CR15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0092-8674(81)90412-8","volume":"27","author":"M Busslinger","year":"1981","unstructured":"Busslinger, M., Moschonas, N. & Flavell, R. \u03b2 + thalassemia: aberrant splicing results from a single point mutation in an intron. Cell 27, 289\u2013298 (1981).","journal-title":"Cell"},{"key":"947_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/0092-8674(82)90452-4","volume":"29","author":"R Treisman","year":"1982","unstructured":"Treisman, R., Proudfoot, N. J., Shander, M. & Maniatis, T. A single-base change at a splice site in a \u03b20-thalassemic gene causes abnormal RNA splicing. Cell 29, 903\u2013911 (1982).","journal-title":"Cell"},{"key":"947_CR17","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.1016\/S0021-9258(20)65092-X","volume":"257","author":"M Poncz","year":"1982","unstructured":"Poncz, M. et al. beta-Thalassemia in a Kurdish Jew. Single base changes in the T-A-T-A box. J. Biol. Chem. 257, 5994\u20135996 (1982).","journal-title":"J. Biol. Chem."},{"key":"947_CR18","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1126\/science.144.3623.1229","volume":"144","author":"CT Rudkin","year":"1964","unstructured":"Rudkin, C. T., Hungerford, D. A. & Nowell, P. C. DNA contents of chromosome PH1 and chromosome 21 in human chronic granulocytic leukemia. Science 144, 1229\u20131231 (1964).","journal-title":"Science"},{"key":"947_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/0092-8674(87)90584-8","volume":"51","author":"F Grosveld","year":"1987","unstructured":"Grosveld, F., van Assendelft, G. B., Greaves, D. R. & Kollias, G. Position-independent, high-level expression of the human \u03b2-globin gene in transgenic mice. Cell 51, 975\u2013985 (1987).","journal-title":"Cell"},{"key":"947_CR20","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1182\/blood.2021013523","volume":"139","author":"MR Niewisch","year":"2022","unstructured":"Niewisch, M. R. et al. Disease progression and clinical outcomes in telomere biology disorders. Blood 139, 1807\u20131819 (2022).","journal-title":"Blood"},{"key":"947_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/ng0598-32","volume":"19","author":"NS Heiss","year":"1998","unstructured":"Heiss, N. S. et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19, 32\u201338 (1998).","journal-title":"Nat. Genet."},{"key":"947_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/990141","volume":"402","author":"JR Mitchell","year":"1999","unstructured":"Mitchell, J. R., Wood, E. & Collins, K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551\u2013555 (1999).","journal-title":"Nature"},{"key":"947_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1006\/bcmd.2001.0389","volume":"27","author":"TJ Vulliamy","year":"2001","unstructured":"Vulliamy, T. J., Knight, S. W., Mason, P. J. & Dokal, I. Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cell Mol. Dis. 27, 353\u2013357 (2001).","journal-title":"Blood Cell Mol. Dis."},{"key":"947_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41576-022-00527-z","volume":"24","author":"P Revy","year":"2023","unstructured":"Revy, P., Kannengiesser, C. & Bertuch, A. A. Genetics of human telomere biology disorders. Nat. Rev. Genet. 24, 86\u2013108 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"947_CR25","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1172\/JCI78963","volume":"125","author":"H Tummala","year":"2015","unstructured":"Tummala, H. et al. Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. J. Clin. Invest. 125, 2151\u20132160 (2015).","journal-title":"J. Clin. Invest."},{"key":"947_CR26","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.ajhg.2022.06.014","volume":"109","author":"H Tummala","year":"2022","unstructured":"Tummala, H. et al. Germline thymidylate synthase deficiency impacts nucleotide metabolism and causes dyskeratosis congenita. Am. J. Hum. Genet. 109, 1472\u20131483 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR27","doi-asserted-by":"publisher","first-page":"7552","DOI":"10.1073\/pnas.0701009104","volume":"104","author":"KD Tsakiri","year":"2007","unstructured":"Tsakiri, K. D. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl Acad. Sci. USA 104, 7552\u20137557 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"947_CR28","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/humu.23898","volume":"40","author":"LM Dodson","year":"2019","unstructured":"Dodson, L. M. et al. From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants. Hum. Mutat. 40, 2414\u20132429 (2019).","journal-title":"Hum. Mutat."},{"key":"947_CR29","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.1172\/JCI120851","volume":"129","author":"EJ McNally","year":"2019","unstructured":"McNally, E. J., Luncsford, P. J. & Armanios, M. Long telomeres and cancer risk: the price of cellular immortality. J. Clin. Invest. 129, 3474\u20133481 (2019).","journal-title":"J. Clin. Invest."},{"key":"947_CR30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2300503","author":"EA DeBoy","year":"2023","unstructured":"DeBoy, E. A. et al. Familial clonal hematopoiesis in a long telomere syndrome. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2300503 (2023).","journal-title":"N. Engl. J. Med."},{"key":"947_CR31","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1038\/s41588-025-02296-x","volume":"57","author":"MA McLoughlin","year":"2025","unstructured":"McLoughlin, M. A. et al. Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis. Nat. Genet. 57, 2215\u20132225 (2025).","journal-title":"Nat. Genet."},{"key":"947_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1146\/annurev-genom-010422-091101","volume":"23","author":"M Armanios","year":"2022","unstructured":"Armanios, M. The role of telomeres in human disease. Annu. Rev. Genomics Hum. Genet. 23, 363\u2013381 (2022).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"947_CR33","first-page":"257","volume":"117","author":"G Fanconi","year":"1927","unstructured":"Fanconi, G. Famili\u00e4re infantile perniciosaartige An\u00e4mie (pernizi\u00f6ses Blutbild und Konstitution). Jahb Kinderheikd 117, 257\u2013280 (1927).","journal-title":"Jahb Kinderheikd"},{"key":"947_CR34","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/356763a0","volume":"356","author":"CA Strathdee","year":"1992","unstructured":"Strathdee, C. A., Gavish, H., Shannon, W. R. & Buchwald, M. Cloning of cDNAs for Fanconi\u2019s anaemia by functional complementation. Nature 356, 763\u2013767 (1992).","journal-title":"Nature"},{"key":"947_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/ng1196-324","volume":"14","author":"Fanconi anaemia\/Breast cancer consortium.","year":"1996","unstructured":"Fanconi anaemia\/Breast cancer consortium. Positional cloning of the Fanconi anaemia group A gene. Nat. Genet. 14, 324\u2013328 (1996).","journal-title":"Nat. Genet."},{"key":"947_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrm.2016.48","volume":"17","author":"R Ceccaldi","year":"2016","unstructured":"Ceccaldi, R., Sarangi, P. & D\u2019Andrea, A. D. The Fanconi anaemia pathway: new players and new functions. Nat. Rev. Mol. Cell Biol. 17, 337\u2013349 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"947_CR37","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1126\/science.1073834","volume":"297","author":"NG Howlett","year":"2002","unstructured":"Howlett, N. G. et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606\u2013609 (2002).","journal-title":"Science"},{"key":"947_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ng.750","volume":"43","author":"Y Kim","year":"2011","unstructured":"Kim, Y. et al. Mutations of the SLX4 gene in Fanconi anemia. Nat. Genet. 43, 142\u2013146 (2011).","journal-title":"Nat. Genet."},{"key":"947_CR39","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ajhg.2013.04.002","volume":"92","author":"M Bogliolo","year":"2013","unstructured":"Bogliolo, M. et al. Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am. J. Hum. Genet. 92, 800\u2013806 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR40","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ajhg.2014.01.007","volume":"94","author":"H Tummala","year":"2014","unstructured":"Tummala, H. et al. ERCC6L2 mutations link a distinct bone-marrow-failure syndrome to DNA repair and mitochondrial function. Am. J. Hum. Genet. 94, 246\u2013256 (2014).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR41","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ccell.2015.03.017","volume":"27","author":"C Polprasert","year":"2015","unstructured":"Polprasert, C. et al. Inherited and somatic defects in DDX41 in myeloid neoplasms. Cancer Cell 27, 658\u2013670 (2015).","journal-title":"Cancer Cell"},{"key":"947_CR42","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.devcel.2021.02.006","volume":"56","author":"JT Weinreb","year":"2021","unstructured":"Weinreb, J. T. et al. Excessive R-loops trigger an inflammatory cascade leading to increased HSPC production. Dev. Cell 56, 627\u2013640.e5 (2021).","journal-title":"Dev. Cell"},{"key":"947_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41375-023-02101-w","volume":"38","author":"Y Liu","year":"2024","unstructured":"Liu, Y. & Karlsson, S. Perspectives of current understanding and therapeutics of Diamond-Blackfan anemia. Leukemia 38, 1\u20139 (2024).","journal-title":"Leukemia"},{"key":"947_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/5951","volume":"21","author":"N Draptchinskaia","year":"1999","unstructured":"Draptchinskaia, N. et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet. 21, 169\u2013175 (1999).","journal-title":"Nat. Genet."},{"key":"947_CR45","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ng0897-368","volume":"16","author":"P Gustavsson","year":"1997","unstructured":"Gustavsson, P. et al. Diamond-Blackfan anaemia: genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 Mb. Nat. Genet. 16, 368\u2013371 (1997).","journal-title":"Nat. Genet."},{"key":"947_CR46","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.ajhg.2018.10.027","volume":"103","author":"JC Ulirsch","year":"2018","unstructured":"Ulirsch, J. C. et al. The genetic landscape of Diamond-Blackfan anemia. Am. J. Hum. Genet. 103, 930\u2013947 (2018).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR47","doi-asserted-by":"publisher","first-page":"eaan2755","DOI":"10.1126\/science.aan2755","volume":"358","author":"EW Mills","year":"2017","unstructured":"Mills, E. W. & Green, R. Ribosomopathies: there\u2019s strength in numbers. Science 358, eaan2755 (2017).","journal-title":"Science"},{"key":"947_CR48","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1182\/blood-2010-07-295238","volume":"117","author":"S Dutt","year":"2011","unstructured":"Dutt, S. et al. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 117, 2567\u20132576 (2011).","journal-title":"Blood"},{"key":"947_CR49","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1172\/JCI63597","volume":"122","author":"VG Sankaran","year":"2012","unstructured":"Sankaran, V. G. et al. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J. Clin. Invest. 122, 2439\u20132443 (2012).","journal-title":"J. Clin. Invest."},{"key":"947_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.cell.2018.02.036","volume":"173","author":"RK Khajuria","year":"2018","unstructured":"Khajuria, R. K. et al. Ribosome levels selectively regulate translation and lineage commitment in human hematopoiesis. Cell 173, 90\u2013103.e19 (2018). This study demonstrated that ribosomal protein haploinsufficiency selectively impairs GATA1 translation, unifying the molecular basis of Diamond\u2013Blackfan anemia.","journal-title":"Cell"},{"key":"947_CR51","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nm.3557","volume":"20","author":"LS Ludwig","year":"2014","unstructured":"Ludwig, L. S. et al. Altered translation of GATA1 in Diamond-Blackfan anemia. Nat. Med. 20, 748\u2013753 (2014).","journal-title":"Nat. Med."},{"key":"947_CR52","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1126\/science.1234864","volume":"340","author":"A Bolze","year":"2013","unstructured":"Bolze, A. et al. Ribosomal protein SA haploinsufficiency in humans with isolated congenital asplenia. Science 340, 976\u2013978 (2013).","journal-title":"Science"},{"key":"947_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.stem.2024.10.012","volume":"32","author":"RA Voit","year":"2025","unstructured":"Voit, R. A. et al. Regulated GATA1 expression as a universal gene therapy for Diamond-Blackfan anemia. Cell Stem Cell 32, 38\u201352.e6 (2025).","journal-title":"Cell Stem Cell"},{"key":"947_CR54","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1086\/319505","volume":"68","author":"S Goobie","year":"2001","unstructured":"Goobie, S. et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am. J. Hum. Genet. 68, 1048\u20131054 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng1062","volume":"33","author":"GRB Boocock","year":"2003","unstructured":"Boocock, G. R. B. et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat. Genet. 33, 97\u2013101 (2003).","journal-title":"Nat. Genet."},{"key":"947_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ng1994","volume":"39","author":"TF Menne","year":"2007","unstructured":"Menne, T. F. et al. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat. Genet. 39, 486\u2013495 (2007).","journal-title":"Nat. Genet."},{"key":"947_CR57","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/blood-2007-02-075184","volume":"110","author":"KA Ganapathi","year":"2007","unstructured":"Ganapathi, K. A. et al. The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood 110, 1458\u20131465 (2007).","journal-title":"Blood"},{"key":"947_CR58","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2016-08-735431","volume":"129","author":"S Dhanraj","year":"2017","unstructured":"Dhanraj, S. et al. Biallelic mutations in DNAJC21 cause Shwachman-Diamond syndrome. Blood 129, 1557\u20131562 (2017).","journal-title":"Blood"},{"key":"947_CR59","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1172\/JCI92876","volume":"127","author":"R Carapito","year":"2017","unstructured":"Carapito, R. et al. Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman-Diamond-like features. J. Clin. Invest. 127, 4090\u20134103 (2017).","journal-title":"J. Clin. Invest."},{"key":"947_CR60","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1182\/blood.2018893404","volume":"134","author":"S Tan","year":"2019","unstructured":"Tan, S. et al. EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome. Blood 134, 277\u2013290 (2019).","journal-title":"Blood"},{"key":"947_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ajhg.2016.05.002","volume":"99","author":"H Tummala","year":"2016","unstructured":"Tummala, H. et al. DNAJC21 mutations link a cancer-prone bone marrow failure syndrome to corruption in 60S ribosome subunit maturation. Am. J. Hum. Genet. 99, 115\u2013124 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR62","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125690","volume":"5","author":"JI Belle","year":"2020","unstructured":"Belle, J. I. et al. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction. JCI Insight 5, e125690 (2020).","journal-title":"JCI Insight"},{"key":"947_CR63","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","volume":"186","author":"J Zhao","year":"2023","unstructured":"Zhao, J. et al. Human hematopoietic stem cell vulnerability to ferroptosis. Cell 186, 732\u2013747.e16 (2023).","journal-title":"Cell"},{"key":"947_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13035","volume":"509","author":"RAJ Signer","year":"2014","unstructured":"Signer, R. A. J., Magee, J. A., Salic, A. & Morrison, S. J. Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature 509, 49\u201354 (2014).","journal-title":"Nature"},{"key":"947_CR65","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1182\/blood-2006-11-057299","volume":"110","author":"DS Grenda","year":"2007","unstructured":"Grenda, D. S. et al. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood 110, 4179\u20134187 (2007).","journal-title":"Blood"},{"key":"947_CR66","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ng.923","volume":"43","author":"P Ostergaard","year":"2011","unstructured":"Ostergaard, P. et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 43, 929\u2013931 (2011).","journal-title":"Nat. Genet."},{"key":"947_CR67","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1182\/blood-2011-05-356352","volume":"118","author":"AP Hsu","year":"2011","unstructured":"Hsu, A. P. et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118, 2653\u20132655 (2011).","journal-title":"Blood"},{"key":"947_CR68","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/ng.913","volume":"43","author":"CN Hahn","year":"2011","unstructured":"Hahn, C. N. et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43, 1012\u20131017 (2011).","journal-title":"Nat. Genet."},{"key":"947_CR69","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/blood-2011-06-360313","volume":"118","author":"RE Dickinson","year":"2011","unstructured":"Dickinson, R. E. et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. Blood 118, 2656\u20132658 (2011).","journal-title":"Blood"},{"key":"947_CR70","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood.2022017764","volume":"141","author":"KR Calvo","year":"2023","unstructured":"Calvo, K. R. & Hickstein, D. D. The spectrum of GATA2 deficiency syndrome. Blood 141, 1524\u20131532 (2023).","journal-title":"Blood"},{"key":"947_CR71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41590-022-01370-4","volume":"24","author":"RA Voit","year":"2023","unstructured":"Voit, R. A. et al. A genetic disorder reveals a hematopoietic stem cell regulatory network co-opted in leukemia. Nat. Immunol. 24, 69\u201383 (2023).","journal-title":"Nat. Immunol."},{"key":"947_CR72","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1182\/blood.2025028954","volume":"146","author":"TJ Fleming","year":"2025","unstructured":"Fleming, T. J. et al. CEBPA repression by MECOM blocks differentiation to drive aggressive leukemias. Blood 146, 3019\u20133035 (2025).","journal-title":"Blood"},{"key":"947_CR73","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1182\/bloodadvances.2023011165","volume":"8","author":"K Yu","year":"2024","unstructured":"Yu, K. et al. Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy. Blood Adv. 8, 497\u2013511 (2024).","journal-title":"Blood Adv."},{"key":"947_CR74","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/13793","volume":"23","author":"WJ Song","year":"1999","unstructured":"Song, W. J. et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat. Genet. 23, 166\u2013175 (1999).","journal-title":"Nat. Genet."},{"key":"947_CR75","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1182\/bloodadvances.2019000785","volume":"4","author":"DC Bellissimo","year":"2020","unstructured":"Bellissimo, D. C. et al. Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signaling. Blood Adv. 4, 1145\u20131158 (2020).","journal-title":"Blood Adv."},{"key":"947_CR76","doi-asserted-by":"publisher","first-page":"eadn9832","DOI":"10.1126\/scitranslmed.adn9832","volume":"17","author":"M Mohammadhosseini","year":"2025","unstructured":"Mohammadhosseini, M. et al. Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in RUNX1-familial platelet disorder. Sci. Transl. Med. 17, eadn9832 (2025).","journal-title":"Sci. Transl. Med."},{"key":"947_CR77","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.3177","volume":"47","author":"MY Zhang","year":"2015","unstructured":"Zhang, M. Y. et al. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy. Nat. Genet. 47, 180\u2013185 (2015).","journal-title":"Nat. Genet."},{"key":"947_CR78","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2018.03.021","volume":"33","author":"ML Churchman","year":"2018","unstructured":"Churchman, M. L. et al. Germline genetic IKZF1 variation and predisposition to childhood acute lymphoblastic leukemia. Cancer Cell 33, 937\u2013948.e8 (2018).","journal-title":"Cancer Cell"},{"key":"947_CR79","doi-asserted-by":"publisher","first-page":"100526","DOI":"10.1016\/j.xgen.2024.100526","volume":"4","author":"AJ de Smith","year":"2024","unstructured":"de Smith, A. J. et al. A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic\/Latino children. Cell Genom. 4, 100526 (2024).","journal-title":"Cell Genom."},{"key":"947_CR80","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1182\/bloodadvances.2022008563","volume":"7","author":"C Escherich","year":"2023","unstructured":"Escherich, C. et al. Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia. Blood Adv. 7, 2177\u20132180 (2023).","journal-title":"Blood Adv."},{"key":"947_CR81","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/ng.2754","volume":"45","author":"S Shah","year":"2013","unstructured":"Shah, S. et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat. Genet. 45, 1226\u20131231 (2013).","journal-title":"Nat. Genet."},{"key":"947_CR82","doi-asserted-by":"publisher","first-page":"920390","DOI":"10.3389\/fgene.2022.920390","volume":"13","author":"R Kingdom","year":"2022","unstructured":"Kingdom, R. & Wright, C. F. Incomplete penetrance and variable expressivity: from clinical studies to population cohorts. Front. Genet. 13, 920390 (2022).","journal-title":"Front. Genet."},{"key":"947_CR83","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.cell.2020.08.008","volume":"182","author":"D Vuckovic","year":"2020","unstructured":"Vuckovic, D. et al. The polygenic and monogenic basis of blood traits and diseases. Cell 182, 1214\u20131231.e11 (2020). This large-scale GWAS defined the polygenic and monogenic architecture of blood cell traits, linking common variants to rare disease genes.","journal-title":"Cell"},{"key":"947_CR84","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1038\/s41588-025-02212-3","volume":"57","author":"IS Forrest","year":"2025","unstructured":"Forrest, I. S. et al. Using large-scale population-based data to improve disease risk assessment of clinical variants. Nat. Genet. 57, 1588\u20131597 (2025).","journal-title":"Nat. Genet."},{"key":"947_CR85","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.ajhg.2022.05.008","volume":"109","author":"AR Barton","year":"2022","unstructured":"Barton, A. R., Hujoel, M. L. A., Mukamel, R. E., Sherman, M. A. & Loh, P.-R. A spectrum of recessiveness among Mendelian disease variants in UK Biobank. Am. J. Hum. Genet. 109, 1298\u20131307 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR86","doi-asserted-by":"publisher","unstructured":"Judd, J. et al. Allele frequencies at recessive disease genes are mainly determined by pleiotropic effects in heterozygotes. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2025.12.05.692665 (2025).","DOI":"10.64898\/2025.12.05.692665"},{"key":"947_CR87","doi-asserted-by":"publisher","DOI":"10.1172\/JCI191107","volume":"135","author":"M Poeschla","year":"2025","unstructured":"Poeschla, M. et al. Polygenic modifiers impact penetrance and expressivity in telomere biology disorders. J. Clin. Invest. 135, e191107 (2025).","journal-title":"J. Clin. Invest."},{"key":"947_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040624","volume":"7","author":"JE van Loon","year":"2012","unstructured":"van Loon, J. E. et al. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients. PLoS ONE 7, e40624 (2012).","journal-title":"PLoS ONE"},{"key":"947_CR89","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41576-019-0139-x","volume":"20","author":"P Revy","year":"2019","unstructured":"Revy, P., Kannengiesser, C. & Fischer, A. Somatic genetic rescue in Mendelian haematopoietic diseases. Nat. Rev. Genet. 20, 582\u2013598 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"947_CR90","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.ajhg.2023.06.009","volume":"110","author":"MH Wojcik","year":"2023","unstructured":"Wojcik, M. H. et al. Beyond the exome: what\u2019s next in diagnostic testing for Mendelian conditions. Am. J. Hum. Genet. 110, 1229\u20131248 (2023).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR91","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41576-024-00808-9","volume":"26","author":"RL Collins","year":"2025","unstructured":"Collins, R. L. & Talkowski, M. E. Diversity and consequences of structural variation in the human genome. Nat. Rev. Genet. 26, 443\u2013462 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"947_CR92","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-025-09140-6","volume":"644","author":"GA Logsdon","year":"2025","unstructured":"Logsdon, G. A. et al. Complex genetic variation in nearly complete human genomes. Nature 644, 430\u2013441 (2025).","journal-title":"Nature"},{"key":"947_CR93","doi-asserted-by":"publisher","first-page":"100562","DOI":"10.1016\/j.xgen.2024.100562","volume":"4","author":"F Rodriguez-Algarra","year":"2024","unstructured":"Rodriguez-Algarra, F., Evans, D. M. & Rakyan, V. K. Ribosomal DNA copy number variation associates with hematological profiles and renal function in the UK Biobank. Cell Genom. 4, 100562 (2024).","journal-title":"Cell Genom."},{"key":"947_CR94","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1261\/rna.079277.122","volume":"28","author":"N Hug","year":"2022","unstructured":"Hug, N. et al. A dual role for the RNA helicase DHX34 in NMD and pre-mRNA splicing and its function in hematopoietic differentiation. RNA 28, 1224\u20131238 (2022).","journal-title":"RNA"},{"key":"947_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14829-5","volume":"11","author":"A Rio-Machin","year":"2020","unstructured":"Rio-Machin, A. et al. The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants. Nat. Commun. 11, 1044 (2020).","journal-title":"Nat. Commun."},{"key":"947_CR96","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41586-025-09357-5","volume":"646","author":"RJ Hofmeister","year":"2025","unstructured":"Hofmeister, R. J. et al. Parent-of-origin effects on complex traits in up to 236,781 individuals. Nature 646, 647\u2013656 (2025).","journal-title":"Nature"},{"key":"947_CR97","doi-asserted-by":"publisher","first-page":"eadm7066","DOI":"10.1126\/science.adm7066","volume":"389","author":"IS Forrest","year":"2025","unstructured":"Forrest, I. S. et al. Machine learning-based penetrance of genetic variants. Science 389, eadm7066 (2025).","journal-title":"Science"},{"key":"947_CR98","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","volume":"167","author":"WJ Astle","year":"2016","unstructured":"Astle, W. J. et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 167, 1415\u20131429.e19 (2016).","journal-title":"Cell"},{"key":"947_CR99","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJM197406062902302","volume":"290","author":"GD Friedman","year":"1974","unstructured":"Friedman, G. D., Klatsky, A. L. & Siegelaub, A. B. The leukocyte count as a predictor of myocardial infarction. N. Engl. J. Med. 290, 1275\u20131278 (1974).","journal-title":"N. Engl. J. Med."},{"key":"947_CR100","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","volume":"182","author":"M-H Chen","year":"2020","unstructured":"Chen, M.-H. et al. Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations. Cell 182, 1198\u20131213.e14 (2020).","journal-title":"Cell"},{"key":"947_CR101","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41586-025-09720-6","volume":"649","author":"P Wainschtein","year":"2025","unstructured":"Wainschtein, P. et al. Estimation and mapping of the missing heritability of human phenotypes. Nature 649, 1219\u20131227 (2025). This study used whole-genome sequencing to estimate heritability from common and rare variants across the allele frequency spectrum, demonstrating that a majority of narrow-sense heritability for many traits can be attributed to identified genetic variants.","journal-title":"Nature"},{"key":"947_CR102","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/s41588-019-0362-6","volume":"51","author":"JC Ulirsch","year":"2019","unstructured":"Ulirsch, J. C. et al. Interrogation of human hematopoiesis at single-cell and single-variant resolution. Nat. Genet. 51, 683\u2013693 (2019).","journal-title":"Nat. Genet."},{"key":"947_CR103","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-022-05684-z","volume":"614","author":"DJ Weiner","year":"2023","unstructured":"Weiner, D. J. et al. Polygenic architecture of rare coding variation across 394,783 exomes. Nature 614, 492\u2013499 (2023).","journal-title":"Nature"},{"key":"947_CR104","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ajhg.2019.07.003","volume":"105","author":"LJ O\u2019Connor","year":"2019","unstructured":"O\u2019Connor, L. J. et al. Extreme polygenicity of complex traits is explained by negative selection. Am. J. Hum. Genet. 105, 456\u2013476 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR105","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2017.05.038","volume":"169","author":"EA Boyle","year":"2017","unstructured":"Boyle, E. A., Li, Y. I. & Pritchard, J. K. An expanded view of complex traits: from polygenic to omnigenic. Cell 169, 1177\u20131186 (2017).","journal-title":"Cell"},{"key":"947_CR106","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41576-025-00834-1","volume":"26","author":"LS Bicknell","year":"2025","unstructured":"Bicknell, L. S., Hirschhorn, J. N. & Savarirayan, R. The genetic basis of human height. Nat. Rev. Genet. 26, 604\u2013619 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"947_CR107","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41586-022-05275-y","volume":"610","author":"L Yengo","year":"2022","unstructured":"Yengo, L. et al. A saturated map of common genetic variants associated with human height. Nature 610, 704\u2013712 (2022).","journal-title":"Nature"},{"key":"947_CR108","doi-asserted-by":"publisher","unstructured":"Tsuo, K. et al. All of Us diversity and scale improve polygenic prediction contextually with greatest improvements for under-represented populations. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.08.06.606846 (2024).","DOI":"10.1101\/2024.08.06.606846"},{"key":"947_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64236-x","volume":"16","author":"JS Weinstock","year":"2025","unstructured":"Weinstock, J. S. et al. Genetic determinants and genomic consequences of non-leukemogenic somatic point mutations. Nat. Commun. 16, 9194 (2025).","journal-title":"Nat. Commun."},{"key":"947_CR110","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41586-023-05806-1","volume":"616","author":"JS Weinstock","year":"2023","unstructured":"Weinstock, J. S. et al. Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis. Nature 616, 755\u2013763 (2023).","journal-title":"Nature"},{"key":"947_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59525-4","volume":"16","author":"R Xiang","year":"2025","unstructured":"Xiang, R. et al. Genome-wide analyses of variance in blood cell phenotypes provide new insights into complex trait biology and prediction. Nat. Commun. 16, 4260 (2025).","journal-title":"Nat. Commun."},{"key":"947_CR112","doi-asserted-by":"publisher","unstructured":"Pershad, Y., Poisner, H., Corty, R. W., Hellwege, J. N. & Bick, A. G. Variance quantitative trait loci reveal gene-gene interactions which alter blood traits. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2024.09.18.24313883 (2024).","DOI":"10.1101\/2024.09.18.24313883"},{"key":"947_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51744-5","volume":"15","author":"RF Hillary","year":"2024","unstructured":"Hillary, R. F. et al. Systematic discovery of gene-environment interactions underlying the human plasma proteome in UK Biobank. Nat. Commun. 15, 7346 (2024).","journal-title":"Nat. Commun."},{"key":"947_CR114","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841\u2013846 (2003).","journal-title":"Nature"},{"key":"947_CR115","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/nature02041","volume":"425","author":"J Zhang","year":"2003","unstructured":"Zhang, J. et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425, 836\u2013841 (2003).","journal-title":"Nature"},{"key":"947_CR116","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nature09262","volume":"466","author":"S M\u00e9ndez-Ferrer","year":"2010","unstructured":"M\u00e9ndez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829\u2013834 (2010).","journal-title":"Nature"},{"key":"947_CR117","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1182\/blood.2023023788","volume":"144","author":"J Hofmann","year":"2024","unstructured":"Hofmann, J. & Kokkaliaris, K. D. Bone marrow niches for hematopoietic stem cells: life span dynamics and adaptation to acute stress. Blood 144, 21\u201334 (2024).","journal-title":"Blood"},{"key":"947_CR118","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1182\/blood.2021013220","volume":"139","author":"A Lopez de Lapuente Portilla","year":"2022","unstructured":"Lopez de Lapuente Portilla, A. et al. Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+ cell levels. Blood 139, 1659\u20131669 (2022).","journal-title":"Blood"},{"key":"947_CR119","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.stem.2023.09.013","volume":"30","author":"M Kasbekar","year":"2023","unstructured":"Kasbekar, M., Mitchell, C. A., Proven, M. A. & Passegu\u00e9, E. Hematopoietic stem cells through the ages: a lifetime of adaptation to organismal demands. Cell Stem Cell 30, 1403\u20131420 (2023).","journal-title":"Cell Stem Cell"},{"key":"947_CR120","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","volume":"187","author":"S Bandyopadhyay","year":"2024","unstructured":"Bandyopadhyay, S. et al. Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging. Cell 187, 3120\u20133140.e29 (2024).","journal-title":"Cell"},{"key":"947_CR121","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.tibtech.2025.05.028","volume":"44","author":"PE Bourgine","year":"2025","unstructured":"Bourgine, P. E. Human bone marrow organoids: emerging progress but persisting challenges. Trends Biotechnol. 44, 11\u201321 (2025).","journal-title":"Trends Biotechnol."},{"key":"947_CR122","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41576-025-00869-4","volume":"26","author":"Z Li","year":"2025","unstructured":"Li, Z. & Zhou, X. Towards improved fine-mapping of candidate causal variants. Nat. Rev. Genet. 26, 847\u2013861 (2025).","journal-title":"Nat. Rev. Genet."},{"key":"947_CR123","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1038\/s41588-019-0494-8","volume":"51","author":"I Jung","year":"2019","unstructured":"Jung, I. et al. A compendium of promoter-centered long-range chromatin interactions in the human genome. Nat. Genet. 51, 1442\u20131449 (2019).","journal-title":"Nat. Genet."},{"key":"947_CR124","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41586-021-03446-x","volume":"593","author":"J Nasser","year":"2021","unstructured":"Nasser, J. et al. Genome-wide enhancer maps link risk variants to disease genes. Nature 593, 238\u2013243 (2021).","journal-title":"Nature"},{"key":"947_CR125","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/hmg\/ddac011","volume":"31","author":"B Rowland","year":"2022","unstructured":"Rowland, B. et al. Transcriptome-wide association study in UK Biobank Europeans identifies associations with blood cell traits. Hum. Mol. Genet. 31, 2333\u20132347 (2022).","journal-title":"Hum. Mol. Genet."},{"key":"947_CR126","doi-asserted-by":"publisher","unstructured":"Sheth, M. U. et al. Mapping enhancer-gene regulatory interactions from single-cell data. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.11.23.624931 (2024).","DOI":"10.1101\/2024.11.23.624931"},{"key":"947_CR127","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"key":"947_CR128","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41588-018-0148-2","volume":"50","author":"F Hormozdiari","year":"2018","unstructured":"Hormozdiari, F. et al. Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits. Nat. Genet. 50, 1041\u20131047 (2018).","journal-title":"Nat. Genet."},{"key":"947_CR129","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/s41588-024-01896-3","volume":"56","author":"QS Wang","year":"2024","unstructured":"Wang, Q. S. et al. Statistically and functionally fine-mapped blood eQTLs and pQTLs from 1,405 humans reveal distinct regulation patterns and disease relevance. Nat. Genet. 56, 2054\u20132067 (2024).","journal-title":"Nat. Genet."},{"key":"947_CR130","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41588-025-02096-3","volume":"57","author":"A Tokolyi","year":"2025","unstructured":"Tokolyi, A. et al. The contribution of genetic determinants of blood gene expression and splicing to molecular phenotypes and health outcomes. Nat. Genet. 57, 616\u2013625 (2025).","journal-title":"Nat. Genet."},{"key":"947_CR131","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tig.2020.08.009","volume":"37","author":"BD Umans","year":"2021","unstructured":"Umans, B. D., Battle, A. & Gilad, Y. Where are the disease-associated eQTLs? Trends Genet. 37, 109\u2013124 (2021).","journal-title":"Trends Genet."},{"key":"947_CR132","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41588-023-01529-1","volume":"55","author":"H Mostafavi","year":"2023","unstructured":"Mostafavi, H., Spence, J. P., Naqvi, S. & Pritchard, J. K. Systematic differences in discovery of genetic effects on gene expression and complex traits. Nat. Genet. 55, 1866\u20131875 (2023).","journal-title":"Nat. Genet."},{"key":"947_CR133","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev-genom-101422-100437","volume":"24","author":"JB Kang","year":"2023","unstructured":"Kang, J. B., Raveane, A., Nathan, A., Soranzo, N. & Raychaudhuri, S. Methods and insights from single-cell expression quantitative trait loci. Annu. Rev. Genomics Hum. Genet. 24, 277\u2013303 (2023).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"947_CR134","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41587-022-01341-y","volume":"40","author":"F Yu","year":"2022","unstructured":"Yu, F. et al. Variant to function mapping at single-cell resolution through network propagation. Nat. Biotechnol. 40, 1644\u20131653 (2022).","journal-title":"Nat. Biotechnol."},{"key":"947_CR135","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/s41588-022-01187-9","volume":"54","author":"KA Jagadeesh","year":"2022","unstructured":"Jagadeesh, K. A. et al. Identifying disease-critical cell types and cellular processes by integrating single-cell RNA-sequencing and human genetics. Nat. Genet. 54, 1479\u20131492 (2022).","journal-title":"Nat. Genet."},{"key":"947_CR136","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41588-022-01167-z","volume":"54","author":"MJ Zhang","year":"2022","unstructured":"Zhang, M. J. et al. Polygenic enrichment distinguishes disease associations of individual cells in single-cell RNA-seq data. Nat. Genet. 54, 1572\u20131580 (2022).","journal-title":"Nat. Genet."},{"key":"947_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02725-6","author":"S Zhang","year":"2025","unstructured":"Zhang, S. et al. Single-cell polygenic risk scores dissect cellular and molecular heterogeneity of complex human diseases. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02725-6 (2025).","journal-title":"Nat. Biotechnol."},{"key":"947_CR138","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan, K. et al. Predicting splicing from primary sequence with deep learning. Cell 176, 535\u2013548.e24 (2019).","journal-title":"Cell"},{"key":"947_CR139","doi-asserted-by":"publisher","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","volume":"381","author":"J Cheng","year":"2023","unstructured":"Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).","journal-title":"Science"},{"key":"947_CR140","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1038\/s41588-018-0167-z","volume":"50","author":"L Sundaram","year":"2018","unstructured":"Sundaram, L. et al. Predicting the clinical impact of human mutation with deep neural networks. Nat. Genet. 50, 1161\u20131170 (2018).","journal-title":"Nat. Genet."},{"key":"947_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02664-4","volume":"23","author":"T Zeng","year":"2022","unstructured":"Zeng, T. & Li, Y. I. Predicting RNA splicing from DNA sequence using Pangolin. Genome Biol. 23, 103 (2022).","journal-title":"Genome Biol."},{"key":"947_CR142","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"947_CR143","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s41586-025-10014-0","volume":"649","author":"\u017d Avsec","year":"2026","unstructured":"Avsec, \u017d. et al. Advancing regulatory variant effect prediction with AlphaGenome. Nature 649, 1206\u20131218 (2026).","journal-title":"Nature"},{"key":"947_CR144","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41592-021-01252-x","volume":"18","author":"\u017d Avsec","year":"2021","unstructured":"Avsec, \u017d et al. Effective gene expression prediction from sequence by integrating long-range interactions. Nat. Methods 18, 1196\u20131203 (2021).","journal-title":"Nat. Methods"},{"key":"947_CR145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43586-021-00093-4","volume":"2","author":"C Bock","year":"2022","unstructured":"Bock, C. et al. High-content CRISPR screening. Nat. Rev. Methods Primers 2, 1\u201323 (2022).","journal-title":"Nat. Rev. Methods Primers"},{"key":"947_CR146","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.ads7951","volume":"388","author":"JD Martin-Rufino","year":"2025","unstructured":"Martin-Rufino, J. D. et al. Transcription factor networks disproportionately enrich for heritability of blood cell phenotypes. Science 388, 52\u201359 (2025).","journal-title":"Science"},{"key":"947_CR147","doi-asserted-by":"publisher","first-page":"eadh7699","DOI":"10.1126\/science.adh7699","volume":"380","author":"JA Morris","year":"2023","unstructured":"Morris, J. A. et al. Discovery of target genes and pathways at GWAS loci by pooled single-cell CRISPR screens. Science 380, eadh7699 (2023).","journal-title":"Science"},{"key":"947_CR148","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/s41588-023-01471-2","volume":"55","author":"D Lara-Astiaso","year":"2023","unstructured":"Lara-Astiaso, D. et al. In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis. Nat. Genet. 55, 1542\u20131554 (2023).","journal-title":"Nat. Genet."},{"key":"947_CR149","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41580-023-00697-6","volume":"25","author":"L Villiger","year":"2024","unstructured":"Villiger, L. et al. CRISPR technologies for genome, epigenome and transcriptome editing. Nat. Rev. Mol. Cell Biol. 25, 464\u2013487 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"947_CR150","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1016\/j.cell.2023.03.035","volume":"184","author":"JD Martin-Rufino","year":"2023","unstructured":"Martin-Rufino, J. D. et al. Massively parallel base editing to map variant effects in human hematopoiesis. Cell 184, 2456\u20132474.e24 (2023).\u00a0This study used massively parallel base editing to systematically map variant effects on haematopoietic differentiation at single-nucleotide resolution.","journal-title":"Cell"},{"key":"947_CR151","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824\u2013844 (2020).","journal-title":"Nat. Biotechnol."},{"key":"947_CR152","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1016\/j.cell.2025.03.034","volume":"188","author":"GE Martyn","year":"2025","unstructured":"Martyn, G. E. et al. Rewriting regulatory DNA to dissect and reprogram gene expression. Cell 188, 3349\u20133366.e23 (2025).","journal-title":"Cell"},{"key":"947_CR153","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1016\/j.cell.2025.04.017","volume":"188","author":"R Fr\u00f6mel","year":"2025","unstructured":"Fr\u00f6mel, R. et al. Design principles of cell-state-specific enhancers in hematopoiesis. Cell 188, 3202\u20133218.e21 (2025).","journal-title":"Cell"},{"key":"947_CR154","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.cell.2016.04.048","volume":"165","author":"JC Ulirsch","year":"2016","unstructured":"Ulirsch, J. C. et al. Systematic functional dissection of common genetic variation affecting red blood cell traits. Cell 165, 1530\u20131545 (2016).","journal-title":"Cell"},{"key":"947_CR155","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.cell.2016.04.027","volume":"165","author":"R Tewhey","year":"2016","unstructured":"Tewhey, R. et al. Direct identification of hundreds of expression-modulating variants using a multiplexed reporter assay. Cell 165, 1519\u20131529 (2016).","journal-title":"Cell"},{"key":"947_CR156","doi-asserted-by":"publisher","unstructured":"Nguyen, T. et al. Systematic functional dissection of germline noncoding risk variants impacting clonal hematopoiesis. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.01.21.700897 (2026).","DOI":"10.64898\/2026.01.21.700897"},{"key":"947_CR157","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41576-025-00900-8","volume":"27","author":"IJ Kullo","year":"2026","unstructured":"Kullo, I. J. Clinical use of polygenic risk scores: current status, barriers and future directions. Nat. Rev. Genet.\u00a027, 246\u2013263 (2026).","journal-title":"Nat. Rev. Genet."},{"key":"947_CR158","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","volume":"28","author":"L Hao","year":"2022","unstructured":"Hao, L. et al. Development of a clinical polygenic risk score assay and reporting workflow. Nat. Med. 28, 1006\u20131013 (2022).","journal-title":"Nat. Med."},{"key":"947_CR159","doi-asserted-by":"publisher","first-page":"ky067","DOI":"10.1093\/jncics\/pky067","volume":"2","author":"M Eklund","year":"2018","unstructured":"Eklund, M. et al. The WISDOM personalized breast cancer screening trial: simulation study to assess potential bias and analytic approaches. JNCI Cancer Spectr. 2, ky067 (2018).","journal-title":"JNCI Cancer Spectr."},{"key":"947_CR160","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.xgen.2021.100086","volume":"2","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Machine learning optimized polygenic scores for blood cell traits identify sex-specific trajectories and genetic correlations with disease. Cell Genom. 2, 100086 (2022).","journal-title":"Cell Genom."},{"key":"947_CR161","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood.2023020118","volume":"142","author":"L Stefanucci","year":"2023","unstructured":"Stefanucci, L. et al. The effects of pathogenic and likely pathogenic variants for inherited hemostasis disorders in 140 214 UK Biobank participants. Blood 142, 2055\u20132068 (2023).","journal-title":"Blood"},{"key":"947_CR162","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41588-023-01638-x","volume":"56","author":"J Guo","year":"2024","unstructured":"Guo, J. et al. Inherited polygenic effects on common hematological traits influence clonal selection on JAK2V617F and the development of myeloproliferative neoplasms. Nat. Genet. 56, 273\u2013280 (2024).","journal-title":"Nat. Genet."},{"key":"947_CR163","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-024-08264-5","volume":"637","author":"BH Foy","year":"2025","unstructured":"Foy, B. H. et al. Haematological setpoints are a stable and patient-specific deep phenotype. Nature 637, 430\u2013438 (2025).","journal-title":"Nature"},{"key":"947_CR164","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","volume":"606","author":"E Mitchell","year":"2022","unstructured":"Mitchell, E. et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature 606, 343\u2013350 (2022). This study phylogenetically reconstructed haematopoietic stem cell dynamics across the human lifespan, which revealed that driver mutations can arise decades before clonal expansion.","journal-title":"Nature"},{"key":"947_CR165","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1016\/j.celrep.2018.11.014","volume":"25","author":"FG Osorio","year":"2018","unstructured":"Osorio, F. G. et al. Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis. Cell Rep. 25, 2308\u20132316.e4 (2018).","journal-title":"Cell Rep."},{"key":"947_CR166","doi-asserted-by":"publisher","first-page":"eaan4673","DOI":"10.1126\/science.aan4673","volume":"366","author":"S Jaiswal","year":"2019","unstructured":"Jaiswal, S. & Ebert, B. L. Clonal hematopoiesis in human aging and disease. Science 366, eaan4673 (2019).","journal-title":"Science"},{"key":"947_CR167","doi-asserted-by":"publisher","unstructured":"Tang, D., Kamitaki, N., Mukamel, R. E., Rubinacci, S. & Loh, P.-R. Patterns and drivers of 43,617 mosaic chromosomal alterations in blood. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2025.07.30.25332451 (2025).","DOI":"10.1101\/2025.07.30.25332451"},{"key":"947_CR168","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41586-018-0321-x","volume":"559","author":"P-R Loh","year":"2018","unstructured":"Loh, P.-R. et al. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. Nature 559, 350\u2013355 (2018).","journal-title":"Nature"},{"key":"947_CR169","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41588-023-01553-1","volume":"55","author":"YA Jakubek","year":"2023","unstructured":"Jakubek, Y. A. et al. Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing. Nat. Genet. 55, 1912\u20131919 (2023).","journal-title":"Nat. Genet."},{"key":"947_CR170","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1182\/blood.V83.4.931.931","volume":"83","author":"MF Fey","year":"1994","unstructured":"Fey, M. F. et al. Clonality and X-inactivation patterns in hematopoietic cell populations detected by the highly informative M27\u03b2 DNA probe. Blood 83, 931\u2013938 (1994).","journal-title":"Blood"},{"key":"947_CR171","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1073\/pnas.48.1.9","volume":"48","author":"E Beutler","year":"1962","unstructured":"Beutler, E., Yeh, M. & Fairbanks, V. F. The normal human female as a mosaic of X-chromosome activity: studies using the gene for G-6-PD-deficiency as a marker. Proc. Natl Acad. Sci. USA 48, 9\u201316 (1962).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"947_CR172","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1038\/1971080a0","volume":"197","author":"PA Jacobs","year":"1963","unstructured":"Jacobs, P. A., Brunton, M., Court Brown, W. M., Doll, R. & Goldstein, H. Change of human chromosome count distribution with age: evidence for a sex differences. Nature 197, 1080\u20131081 (1963).","journal-title":"Nature"},{"key":"947_CR173","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1182\/blood.2023022222","volume":"142","author":"LD Weeks","year":"2023","unstructured":"Weeks, L. D. & Ebert, B. L. Causes and consequences of clonal hematopoiesis. Blood 142, 2235\u20132246 (2023).","journal-title":"Blood"},{"key":"947_CR174","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477\u20132487 (2014).","journal-title":"N. Engl. J. Med."},{"key":"947_CR175","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014). This study (and Genovese, G. et al., 2014) established that age-related clonal haematopoiesis is associated with increased risk of haematological malignancy and cardiovascular disease.","journal-title":"N. Engl. J. Med."},{"key":"947_CR176","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472\u20131478 (2014).","journal-title":"Nat. Med."},{"key":"947_CR177","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41591-021-01521-4","volume":"27","author":"A Niroula","year":"2021","unstructured":"Niroula, A. et al. Distinction of lymphoid and myeloid clonal hematopoiesis. Nat. Med. 27, 1921\u20131927 (2021).","journal-title":"Nat. Med."},{"key":"947_CR178","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-020-2430-6","volume":"584","author":"P-R Loh","year":"2020","unstructured":"Loh, P.-R., Genovese, G. & McCarroll, S. A. Monogenic and polygenic inheritance become instruments for clonal selection. Nature 584, 136\u2013141 (2020).","journal-title":"Nature"},{"key":"947_CR179","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41586-019-1765-3","volume":"575","author":"DJ Thompson","year":"2019","unstructured":"Thompson, D. J. et al. Genetic predisposition to mosaic Y chromosome loss in blood. Nature 575, 652\u2013657 (2019).","journal-title":"Nature"},{"key":"947_CR180","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1038\/s41588-023-01555-z","volume":"55","author":"SN Stacey","year":"2023","unstructured":"Stacey, S. N. et al. Genetics and epidemiology of mutational barcode-defined clonal hematopoiesis. Nat. Genet. 55, 2149\u20132159 (2023).","journal-title":"Nat. Genet."},{"key":"947_CR181","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink, F. et al. Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130, 742\u2013752 (2017).","journal-title":"Blood"},{"key":"947_CR182","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-022-05448-9","volume":"612","author":"MD Kessler","year":"2022","unstructured":"Kessler, M. D. et al. Common and rare variant associations with clonal haematopoiesis phenotypes. Nature 612, 301\u2013309 (2022).","journal-title":"Nature"},{"key":"947_CR183","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41586-020-2426-2","volume":"584","author":"C Terao","year":"2020","unstructured":"Terao, C. et al. Chromosomal alterations among age-related haematopoietic clones in Japan. Nature 584, 130\u2013135 (2020).","journal-title":"Nature"},{"key":"947_CR184","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41591-021-01371-0","volume":"27","author":"SM Zekavat","year":"2021","unstructured":"Zekavat, S. M. et al. Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection. Nat. Med. 27, 1012\u20131024 (2021).","journal-title":"Nat. Med."},{"key":"947_CR185","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1126\/science.abn3100","volume":"377","author":"S Sano","year":"2022","unstructured":"Sano, S. et al. Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality. Science 377, 292\u2013297 (2022).","journal-title":"Science"},{"key":"947_CR186","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s44161-024-00441-z","volume":"3","author":"K Horitani","year":"2024","unstructured":"Horitani, K. et al. Disruption of the Uty epigenetic regulator locus in hematopoietic cells phenocopies the profibrotic attributes of Y chromosome loss in heart failure. Nat. Cardiovasc. Res. 3, 343\u2013355 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"947_CR187","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41591-025-03623-9","volume":"31","author":"R Molteni","year":"2025","unstructured":"Molteni, R. et al. Mechanisms of hematopoietic clonal dominance in VEXAS syndrome. Nat. Med. 31, 1911\u20131924 (2025).","journal-title":"Nat. Med."},{"key":"947_CR188","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1038\/s41588-025-02250-x","volume":"57","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy. Nat. Genet. 57, 1872\u20131880 (2025).","journal-title":"Nat. Genet."},{"key":"947_CR189","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41586-020-2819-2","volume":"586","author":"AG Bick","year":"2020","unstructured":"Bick, A. G. et al. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature 586, 763\u2013768 (2020).","journal-title":"Nature"},{"key":"947_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41315-5","volume":"14","author":"DW Brown","year":"2023","unstructured":"Brown, D. W. et al. Shared and distinct genetic etiologies for different types of clonal hematopoiesis. Nat. Commun. 14, 5536 (2023).","journal-title":"Nat. Commun."},{"key":"947_CR191","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025031266","author":"D Ranasinghe","year":"2026","unstructured":"Ranasinghe, D. et al. Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia. Blood https:\/\/doi.org\/10.1182\/blood.2025031266 (2026).","journal-title":"Blood"},{"key":"947_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20565-7","volume":"12","author":"T Gao","year":"2021","unstructured":"Gao, T. et al. Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis. Nat. Commun. 12, 338 (2021).","journal-title":"Nat. Commun."},{"key":"947_CR193","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21588-4","volume":"12","author":"AL Kennedy","year":"2021","unstructured":"Kennedy, A. L. et al. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nat. Commun. 12, 1334 (2021).","journal-title":"Nat. Commun."},{"key":"947_CR194","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1182\/blood-2015-04-641100","volume":"126","author":"JE Churpek","year":"2015","unstructured":"Churpek, J. E. et al. Genomic analysis of germ line and somatic variants in familial myelodysplasia\/acute myeloid leukemia. Blood 126, 2484\u20132490 (2015).","journal-title":"Blood"},{"key":"947_CR195","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","volume":"4","author":"AL Brown","year":"2020","unstructured":"Brown, A. L. et al. RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML. Blood Adv. 4, 1131\u20131144 (2020).","journal-title":"Blood Adv."},{"key":"947_CR196","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1126\/science.adx4174","volume":"391","author":"G Agarwal","year":"2026","unstructured":"Agarwal, G. et al. Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation. Science 391, 52\u201358 (2026). This paper showed that a common inherited variant can reduce clonal haematopoiesis risk by limiting haematopoietic stem cell self-renewal, linking germline variation to protection from somatic clonal expansion and cancer.","journal-title":"Science"},{"key":"947_CR197","doi-asserted-by":"publisher","unstructured":"Lyu, P. et al. Genetic variation reveals a homeotic long noncoding RNA that modulates human hematopoietic stem cells. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.07.16.664824 (2025).","DOI":"10.1101\/2025.07.16.664824"},{"key":"947_CR198","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.119.044362","volume":"141","author":"AG Bick","year":"2020","unstructured":"Bick, A. G. et al. Genetic interleukin 6 signaling deficiency attenuates cardiovascular risk in clonal hematopoiesis. Circulation 141, 124\u2013131 (2020).","journal-title":"Circulation"},{"key":"947_CR199","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41580-024-00770-8","volume":"26","author":"TL Cain","year":"2025","unstructured":"Cain, T. L., Derecka, M. & McKinney-Freeman, S. The role of the haematopoietic stem cell niche in development and ageing. Nat. Rev. Mol. Cell Biol. 26, 32\u201350 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"947_CR200","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","volume":"606","author":"MA Fabre","year":"2022","unstructured":"Fabre, M. A. et al. The longitudinal dynamics and natural history of clonal haematopoiesis. Nature 606, 335\u2013342 (2022). This study characterized the longitudinal dynamics of clonal haematopoiesis, showing mutation-specific differences in expansion kinetics and malignant risk.","journal-title":"Nature"},{"key":"947_CR201","doi-asserted-by":"publisher","unstructured":"MacGregor, H. A. J., Tran, D., Bolton, K. L., Easton, D. F. & Blundell, J. R. The age-related deceleration of clonal haematopoiesis in 420,000 healthy adults. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.12.21.572706 (2023).","DOI":"10.1101\/2023.12.21.572706"},{"key":"947_CR202","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1182\/blood.2023019964","volume":"143","author":"MA Fabre","year":"2024","unstructured":"Fabre, M. A. & Vassiliou, G. S. The lifelong natural history of clonal hematopoiesis and its links to myeloid neoplasia. Blood 143, 573\u2013581 (2024).","journal-title":"Blood"},{"key":"947_CR203","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1182\/blood.2019001807","volume":"135","author":"MA Fabre","year":"2020","unstructured":"Fabre, M. A. et al. Concordance for clonal hematopoiesis is limited in elderly twins. Blood 135, 269\u2013273 (2020).","journal-title":"Blood"},{"key":"947_CR204","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1182\/blood.2019001793","volume":"135","author":"JW Hansen","year":"2020","unstructured":"Hansen, J. W. et al. Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality. Blood 135, 261\u2013268 (2020).","journal-title":"Blood"},{"key":"947_CR205","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton, K. L. et al. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat. Genet. 52, 1219\u20131226 (2020).","journal-title":"Nat. Genet."},{"key":"947_CR206","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/s41375-020-0896-8","volume":"34","author":"AAZ Dawoud","year":"2020","unstructured":"Dawoud, A. A. Z., Tapper, W. J. & Cross, N. C. P. Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking. Leukemia 34, 2660\u20132672 (2020).","journal-title":"Leukemia"},{"key":"947_CR207","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1158\/2643-3230.BCD-19-0028","volume":"1","author":"A Stoddart","year":"2020","unstructured":"Stoddart, A. et al. Cytotoxic therapy-induced effects on both hematopoietic and marrow stromal cells promotes therapy-related myeloid neoplasms. Blood Cancer Discov. 1, 32\u201347 (2020).","journal-title":"Blood Cancer Discov."},{"key":"947_CR208","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41588-023-01472-1","volume":"55","author":"M Gu","year":"2023","unstructured":"Gu, M. et al. Multiparameter prediction of myeloid neoplasia risk. Nat. Genet. 55, 1523\u20131530 (2023).","journal-title":"Nat. Genet."},{"key":"947_CR209","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41586-024-07066-z","volume":"627","author":"C Weng","year":"2024","unstructured":"Weng, C. et al. Deciphering cell states and genealogies of human haematopoiesis. Nature 627, 389\u2013398 (2024).","journal-title":"Nature"},{"key":"947_CR210","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-025-09584-w","volume":"647","author":"ARJ Lawson","year":"2025","unstructured":"Lawson, A. R. J. et al. Somatic mutation and selection at population scale. Nature 647, 411\u2013420 (2025).","journal-title":"Nature"},{"key":"947_CR211","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1126\/science.aay9333","volume":"367","author":"CJ Watson","year":"2020","unstructured":"Watson, C. J. et al. The evolutionary dynamics and fitness landscape of clonal hematopoiesis. Science 367, 1449\u20131454 (2020).","journal-title":"Science"},{"key":"947_CR212","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/s41588-023-01490-z","volume":"55","author":"CJ Watson","year":"2023","unstructured":"Watson, C. J. & Blundell, J. R. Mutation rates and fitness consequences of mosaic chromosomal alterations in blood. Nat. Genet. 55, 1677\u20131685 (2023).","journal-title":"Nat. Genet."},{"key":"947_CR213","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1126\/science.aau3879","volume":"362","author":"I Martincorena","year":"2018","unstructured":"Martincorena, I. et al. Somatic mutant clones colonize the human esophagus with age. Science 362, 911\u2013917 (2018).","journal-title":"Science"},{"key":"947_CR214","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.cell.2019.03.026","volume":"177","author":"M Zhu","year":"2019","unstructured":"Zhu, M. et al. Somatic mutations increase hepatic clonal fitness and regeneration in chronic liver disease. Cell 177, 608\u2013621.e12 (2019).","journal-title":"Cell"},{"key":"947_CR215","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41586-020-1961-1","volume":"578","author":"K Yoshida","year":"2020","unstructured":"Yoshida, K. et al. Tobacco smoking and somatic mutations in human bronchial epithelium. Nature 578, 266\u2013272 (2020).","journal-title":"Nature"},{"key":"947_CR216","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1126\/science.aaa6806","volume":"348","author":"I Martincorena","year":"2015","unstructured":"Martincorena, I. et al. Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science 348, 880\u2013886 (2015).","journal-title":"Science"},{"key":"947_CR217","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson, M. R. et al. The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856\u2013860 (2015).","journal-title":"Nat. Genet."},{"key":"947_CR218","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","volume":"629","author":"EV Minikel","year":"2024","unstructured":"Minikel, E. V., Painter, J. L., Dong, C. C. & Nelson, M. R. Refining the impact of genetic evidence on clinical success. Nature 629, 624\u2013629 (2024).","journal-title":"Nature"},{"key":"947_CR219","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","volume":"390","author":"H Frangoul","year":"2024","unstructured":"Frangoul, H. et al. Exagamglogene autotemcel for severe sickle cell disease. N. Engl. J. Med. 390, 1649\u20131662 (2024).","journal-title":"N. Engl. J. Med."},{"key":"947_CR220","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa2309673","volume":"390","author":"F Locatelli","year":"2024","unstructured":"Locatelli, F. et al. Exagamglogene autotemcel for transfusion-dependent \u03b2-thalassemia. N. Engl. J. Med. 390, 1663\u20131676 (2024).","journal-title":"N. Engl. J. Med."},{"key":"947_CR221","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2117175","volume":"386","author":"J Kanter","year":"2022","unstructured":"Kanter, J. et al. Biologic and clinical efficacy of LentiGlobin for sickle cell disease. N. Engl. J. Med. 386, 617\u2013628 (2022).","journal-title":"N. Engl. J. Med."},{"key":"947_CR222","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1056\/NEJMoa2113206","volume":"386","author":"F Locatelli","year":"2022","unstructured":"Locatelli, F. et al. Betibeglogene autotemcel gene therapy for non-\u03b20\/\u03b20 genotype \u03b2-thalassemia. N. Engl. J. Med. 386, 415\u2013427 (2022).","journal-title":"N. Engl. J. Med."},{"key":"947_CR223","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1016\/j.ymthe.2025.04.029","volume":"33","author":"T John","year":"2025","unstructured":"John, T. & Czechowicz, A. Clinical hematopoietic stem cell-based gene therapy. Mol. Ther. 33, 2663\u20132678 (2025).","journal-title":"Mol. Ther."},{"key":"947_CR224","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/d41573-025-00036-8","volume":"24","author":"S Phares","year":"2025","unstructured":"Phares, S., Phillip, K. & Trusheim, M. Clinical development success rates for durable cell and gene therapies. Nat. Rev. Drug Discov. 24, 329\u2013330 (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"947_CR225","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02915-2","author":"VV Botchkarev Jr","year":"2025","unstructured":"Botchkarev, V. V. Jr et al. In vivo gene editing of human hematopoietic stem and progenitor cells using envelope-engineered virus-like particles. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02915-2 (2025).","journal-title":"Nat. Biotechnol."},{"key":"947_CR226","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201809958","volume":"11","author":"L Naldini","year":"2019","unstructured":"Naldini, L. Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives. EMBO Mol. Med. 11, e9958 (2019).","journal-title":"EMBO Mol. Med."},{"key":"947_CR227","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha, J. T., Wang, Y., Ma, H., Tai, P. W. L. & Gao, G. Viral vector platforms within the gene therapy landscape. Signal Transduct. Target. Ther. 6, 53 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"947_CR228","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1126\/science.1242088","volume":"342","author":"DE Bauer","year":"2013","unstructured":"Bauer, D. E. et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342, 253\u2013257 (2013).","journal-title":"Science"},{"key":"947_CR229","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.adp3025","volume":"386","author":"G Zheng","year":"2024","unstructured":"Zheng, G. et al. A tetramer of BCL11A is required for stable protein production and fetal hemoglobin silencing. Science 386, 1010\u20131018 (2024).","journal-title":"Science"},{"key":"947_CR230","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30675-z","volume":"13","author":"AC Fahed","year":"2022","unstructured":"Fahed, A. C., Philippakis, A. A. & Khera, A. V. The potential of polygenic scores to improve cost and efficiency of clinical trials. Nat. Commun. 13, 2922 (2022). This study quantified how polygenic risk stratification could improve clinical trial efficiency by enriching for high-risk individuals, reducing sample sizes needed to detect treatment effects.","journal-title":"Nat. Commun."},{"key":"947_CR231","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","volume":"7","author":"EC Svensson","year":"2022","unstructured":"Svensson, E. C. et al. TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiol. 7, 521\u2013528 (2022).","journal-title":"JAMA Cardiol."},{"key":"947_CR232","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24387-z","volume":"12","author":"D Zhou","year":"2021","unstructured":"Zhou, D. et al. Contextualizing genetic risk score for disease screening and rare variant discovery. Nat. Commun. 12, 4418 (2021).","journal-title":"Nat. Commun."},{"key":"947_CR233","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGENETICS.116.001643","volume":"10","author":"D Klarin","year":"2017","unstructured":"Klarin, D., Emdin, C. A., Natarajan, P., Conrad, M. F. & Kathiresan, S. Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ. Cardiovasc. Genet. 10, e001643 (2017).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"947_CR234","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40679-y","volume":"14","author":"P Akbari","year":"2023","unstructured":"Akbari, P. et al. A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology. Nat. Commun. 14, 5023 (2023).","journal-title":"Nat. Commun."},{"key":"947_CR235","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.immuni.2012.08.025","volume":"37","author":"T Griseri","year":"2012","unstructured":"Griseri, T., McKenzie, B. S., Schiering, C. & Powrie, F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 37, 1116\u20131129 (2012).","journal-title":"Immunity"},{"key":"947_CR236","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.1135245","volume":"314","author":"RH Duerr","year":"2006","unstructured":"Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461\u20131463 (2006).","journal-title":"Science"},{"key":"947_CR237","unstructured":"Gusev, S. Gene-environment interactions: ubiquitous yet undetectable. The Infinitesimal https:\/\/theinfinitesimal.substack.com\/p\/gene-environment-interactions-ubiquitous (2024)."},{"key":"947_CR238","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.ajhg.2025.01.014","volume":"112","author":"A Durvasula","year":"2025","unstructured":"Durvasula, A. & Price, A. L. Distinct explanations underlie gene-environment interactions in the UK Biobank. Am. J. Hum. Genet. 112, 644\u2013658 (2025).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR239","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1126\/science.1156409","volume":"322","author":"D Altshuler","year":"2008","unstructured":"Altshuler, D., Daly, M. J. & Lander, E. S. Genetic mapping in human disease. Science 322, 881\u2013888 (2008). This paper outlined the rationale and promise of genetic mapping approaches for human disease, framing the transition from linkage analysis to GWAS.","journal-title":"Science"},{"key":"947_CR240","first-page":"314","volume":"32","author":"D Botstein","year":"1980","unstructured":"Botstein, D., White, R. L., Skolnick, M. & Davis, R. W. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am. J. Hum. Genet. 32, 314\u2013331 (1980).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR241","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0092-8674(87)90158-9","volume":"51","author":"H Donis-Keller","year":"1987","unstructured":"Donis-Keller, H. et al. A genetic linkage map of the human genome. Cell 51, 319\u2013337 (1987).","journal-title":"Cell"},{"key":"947_CR242","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nature04226","volume":"437","author":"International HapMap Consortium","year":"2005","unstructured":"International HapMap Consortium A haplotype map of the human genome. Nature 437, 1299\u20131320 (2005).","journal-title":"Nature"},{"key":"947_CR243","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","volume":"101","author":"PM Visscher","year":"2017","unstructured":"Visscher, P. M. et al. 10 Years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5\u201322 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"947_CR244","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.cell.2024.01.023","volume":"187","author":"T Lappalainen","year":"2024","unstructured":"Lappalainen, T., Li, Y. I., Ramachandran, S. & Gusev, A. Genetic and molecular architecture of complex traits. Cell 187, 1059\u20131075 (2024).","journal-title":"Cell"},{"key":"947_CR245","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrg3031","volume":"12","author":"MJ Bamshad","year":"2011","unstructured":"Bamshad, M. J. et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12, 745\u2013755 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"947_CR246","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","volume":"599","author":"JD Backman","year":"2021","unstructured":"Backman, J. D. et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature 599, 628\u2013634 (2021).","journal-title":"Nature"},{"key":"947_CR247","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s41586-025-09272-9","volume":"645","author":"UK Biobank Whole-Genome Sequencing Consortium.","year":"2025","unstructured":"UK Biobank Whole-Genome Sequencing Consortium. Whole-genome sequencing of 490,640 UK Biobank participants. Nature 645, 692\u2013701 (2025).","journal-title":"Nature"},{"key":"947_CR248","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.aax3710","volume":"365","author":"AI Young","year":"2019","unstructured":"Young, A. I., Benonisdottir, S., Przeworski, M. & Kong, A. Deconstructing the sources of genotype-phenotype associations in humans. Science 365, 1396\u20131400 (2019).","journal-title":"Science"},{"key":"947_CR249","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1136\/bmj.1.4925.1308","volume":"1","author":"GM Edington","year":"1955","unstructured":"Edington, G. M. & Lehmann, H. Expression of the sickle-cell gene in Africa. Br. Med. J. 1, 1308\u20131311 (1955).","journal-title":"Br. Med. J."},{"key":"947_CR250","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1073\/pnas.0711566105","volume":"105","author":"M Uda","year":"2008","unstructured":"Uda, M. et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of \u03b2-thalassemia. Proc. Natl Acad. Sci. USA 105, 1620\u20131625 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"947_CR251","doi-asserted-by":"publisher","first-page":"11869","DOI":"10.1073\/pnas.0804799105","volume":"105","author":"G Lettre","year":"2008","unstructured":"Lettre, G. et al. DNA polymorphisms at the BCL11A, HBS1L-MYB, and \u03b2-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl Acad. Sci. USA 105, 11869\u201311874 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"947_CR252","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ng2108","volume":"39","author":"S Menzel","year":"2007","unstructured":"Menzel, S. et al. A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat. Genet. 39, 1197\u20131199 (2007).","journal-title":"Nat. Genet."},{"key":"947_CR253","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1126\/science.1165409","volume":"322","author":"VG Sankaran","year":"2008","unstructured":"Sankaran, V. G. et al. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322, 1839\u20131842 (2008). This work identified BCL11A as the transcriptional repressor of fetal haemoglobin, establishing the therapeutic target for sickle cell disease gene therapy.","journal-title":"Science"},{"key":"947_CR254","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/nature08243","volume":"460","author":"VG Sankaran","year":"2009","unstructured":"Sankaran, V. G. et al. Developmental and species-divergent globin switching are driven by BCL11A. Nature 460, 1093\u20131097 (2009).","journal-title":"Nature"},{"key":"947_CR255","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1126\/science.1211053","volume":"334","author":"J Xu","year":"2011","unstructured":"Xu, J. et al. Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 334, 993\u2013996 (2011).","journal-title":"Science"},{"key":"947_CR256","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1172\/JCI81163","volume":"125","author":"A Basak","year":"2015","unstructured":"Basak, A. et al. BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations. J. Clin. Invest. 125, 2363\u20132368 (2015).","journal-title":"J. Clin. Invest."},{"key":"947_CR257","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/blood-2015-04-638528","volume":"126","author":"APW Funnell","year":"2015","unstructured":"Funnell, A. P. W. et al. 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment. Blood 126, 89\u201393 (2015).","journal-title":"Blood"},{"key":"947_CR258","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/nature15521","volume":"527","author":"MC Canver","year":"2015","unstructured":"Canver, M. C. et al. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis. Nature 527, 192\u2013197 (2015).","journal-title":"Nature"},{"key":"947_CR259","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/s41588-023-01434-7","volume":"55","author":"T Mayuranathan","year":"2023","unstructured":"Mayuranathan, T. et al. Potent and uniform fetal hemoglobin induction via base editing. Nat. Genet. 55, 1210\u20131220 (2023).","journal-title":"Nat. Genet."},{"key":"947_CR260","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65421","volume":"11","author":"NS Ravi","year":"2022","unstructured":"Ravi, N. S. et al. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin. eLife 11, e65421 (2022).","journal-title":"eLife"}],"container-title":["Nature Reviews Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41576-026-00947-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41576-026-00947-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41576-026-00947-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:02:07Z","timestamp":1784289727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41576-026-00947-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":260,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["947"],"URL":"https:\/\/doi.org\/10.1038\/s41576-026-00947-1","relation":{},"ISSN":["1471-0056","1471-0064"],"issn-type":[{"value":"1471-0056","type":"print"},{"value":"1471-0064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"9 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.G.S. serves as an adviser to Ensoma, Cellarity and Beam Therapeutics, all unrelated to the present work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}